# Integer Holdings Corp > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Integer Holdings Corp). ## Overview Integer Holdings Corp. is a U.S.-based contract development and manufacturing organization focused on medical devices for cardio and vascular, neuromodulation, and cardiac rhythm management markets. It designs and manufactures custom components, assemblies, and system/device solutions for large multinational OEMs, combining engineering, manufacturing, and quality systems under brands such as Greatbatch Medical and Lake Region Medical. ## Products & services • Custom medical device components and assemblies • Cardio and vascular device manufacturing • Neuromodulation device manufacturing • Cardiac rhythm management manufacturing • System and device solutions for OEMs • Engineering, design, and manufacturing support - **Cardio and Vascular CDMO** (40%) — Custom components, assemblies, and manufacturing services for cardiovascular devices. - **Neuromodulation CDMO** (20%) — Manufacturing and engineering support for neuromodulation device platforms. - **Cardiac Rhythm Management CDMO** (20%) — Production of components and assemblies used in rhythm management devices. - **System and Device Solutions** (10%) — Ready-to-market device solutions developed with OEM customers. - **Engineering and Value-Added Services** (10%) — Design, materials selection, process engineering, and program support. - Custom medical device components and assemblies - Cardio and vascular device manufacturing - Neuromodulation device manufacturing - Cardiac rhythm management manufacturing - System and device solutions for OEMs - Engineering, design, and manufacturing support ## Customers Integer sells primarily to large multinational medical device OEMs and their affiliated subsidiaries, with direct sales and long-term supply relationships. Its customers buy because Integer can provide specialized manufacturing, engineering, and quality capabilities that are difficult to replicate in-house, especially for regulated implantable and therapy-delivery devices. Customer concentration is high, with Abbott Laboratories, Boston Scientific, and Medtronic each representing more than 10% of 2025 sales. - **Large multinational medical device OEMs** (primary) — Buy custom components, assemblies, and device solutions for branded medical devices; they value scale, quality, and regulatory execution. - **OEM subsidiaries and operating units** (primary) — Source products through affiliated entities and regional programs, often tied to global supply agreements. - **Cardio and vascular device manufacturers** (primary) — Buy specialized manufacturing for cardiovascular therapies and related components. - **Neuromodulation device manufacturers** (secondary) — Buy manufacturing and engineering support for implantable and therapy-delivery platforms. - **Cardiac rhythm management manufacturers** (secondary) — Buy components and assemblies used in pacemakers and related rhythm management products. - Large multinational medical device OEMs buy custom components and assemblies - OEM subsidiaries buy through direct supply relationships and long-term programs - Cardio, vascular, neuromodulation, and CRM customers need regulated manufacturing - Customers use Integer to add engineering depth and manufacturing scale - Top customers Abbott, Boston Scientific, and Medtronic are strategically important ## Geography Integer is headquartered in Plano, Texas and sells globally, but its customer base is heavily tied to U.S.-headquartered OEMs. In 2025, approximately 53% of products sold were shipped to locations in the United States, showing that the business is operationally concentrated in the U.S. even when end markets are international. Geography matters because supply-chain execution, customer proximity, and regulatory compliance are central to its CDMO model. - Headquartered in Plano, Texas - Approximately 53% of products sold were shipped to U.S. locations in 2025 - Sales outside the U.S. are still often tied to U.S.-headquartered OEMs - Global customer programs require cross-border manufacturing and logistics - Geographic mix affects exposure to customer demand shifts and supply-chain risk ## Strategy Integer is shifting toward higher-growth medtech markets where it has differentiated engineering and manufacturing capabilities. It is also using tuck-in acquisitions to add technologies, expand customer penetration, and deepen its position in targeted therapy areas while maintaining a focus on quality and service. The strategy is designed to strengthen scale, broaden capabilities, and reduce dependence on any single product line or customer. - **Expand in targeted growth medtech markets** (medium-term) — These markets offer stronger long-term demand and fit Integer's engineering and manufacturing strengths. - **Pursue tuck-in acquisitions** (short-term) — Acquisitions add capabilities, brands, and technologies that deepen customer relationships and broaden the platform. - **Increase long-term OEM agreements** (short-term) — Longer contracts help secure the revenue base and improve visibility in a concentrated customer model. - Focus on higher-growth medtech markets with differentiated capabilities - Use tuck-in acquisitions to add technology and complementary products - Expand penetration with existing OEM customers - Build scale in cardio, vascular, neuromodulation, and CRM - Secure longer-term supply agreements to stabilize revenue ## Risks Integer's biggest risk is customer concentration: a small number of OEMs account for a large share of revenue, so demand changes, sourcing shifts, or vertical integration by customers can quickly affect results. The business also faces pricing pressure, product recall exposure through customer programs, cybersecurity and IT disruption risk, and integration risk from acquisitions. As a regulated medical-device supplier, quality failures or supply interruptions can damage customer relationships and lead to lost programs. - **Customer concentration** [high] — Top three customers were about 49% of 2025 sales, so loss or reduction of one account would materially affect revenue. - **Pricing pressure** [high] — OEM customers can demand price reductions, which can reduce operating margins in a contract manufacturing model. - **Customer inventory and sourcing changes** [medium] — Inventory rebalancing, vertical integration, or alternate supply arrangements can reduce shipments unexpectedly. - **Cybersecurity and IT disruption** [medium] — A breach or outage could interrupt manufacturing, expose data, or trigger regulatory and legal costs. - **Acquisition integration risk** [medium] — Recent acquisitions must be integrated without disrupting operations or eroding expected synergies. - High customer concentration can cause large revenue swings - OEM vertical integration or alternate sourcing can displace Integer - Pricing pressure can compress margins in competitive programs - Customer recalls or field actions can disrupt demand and shipments - Cybersecurity or IT failures could interrupt operations and data flows ## Accounting Integer's accounting is shaped by acquisition activity, inventory valuation, and debt/derivative transactions. Investors should watch how purchase accounting, goodwill and intangible assets, inventory reserves, and convertible note/capped call accounting affect reported earnings and balance sheet leverage. Revenue is tied to customer shipments and program timing, so working-capital swings and backlog conversion can also affect quarter-to-quarter comparability. - **Inventory valuation** — Can change gross margin and earnings if demand shifts or products become unsaleable - **Acquisition accounting and goodwill** — Affects amortization expense, goodwill balance, and future impairment charges - **Convertible notes and capped call transactions** — Affects interest expense, equity classification, and diluted EPS - **Revenue recognition and shipment timing** — Can create quarterly volatility in revenue and margins - Acquisition accounting affects goodwill, intangibles, and amortization - Inventory reserves matter because excess or obsolete stock can be written down - Convertible notes and capped calls create derivative and financing complexity - Revenue timing depends on shipment and customer program schedules - Working capital changes can distort cash flow versus earnings trends --- *Last updated: 2026-04-28T20:17:44.547399+00:00*